Thrombolysis in stroke patients: Comparability of point-of-care versus central laboratory international normalized ratio
Open Access
- 10 January 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (1) , e0190867
Abstract
In acute stroke patients, thrombolysis is one gold standard therapy option within the first four hours after the ischemic event. A contraindication for thrombolysis is an International Normalized Ratio (INR) value >1.7. Since time is brain, rapid and reliable INR results are fundamental. Aim was to compare INR values determined by central laboratory (CL) analyzer and Point-of-Care Testing(POCT)-device and to evaluate the quality of POCT performance in cases of potential therapeutic thrombolysis at a certified stroke unit. In 153 patients INR measurements using POCT-devices (HEMOCHRON Signature Elite®) were compared to INR measurements (BCS®XP) performed at the central laboratory. Outlier evaluation was performed regarding the critical thrombolysis cut-off. Overall, we demonstrated a significant correlation (r = 0.809, p75 years. POCT-INR measurements based on our POCT concept are suitable to determine INR values in critical stroke patients. Nevertheless, outlier evaluation is mandatory.Keywords
This publication has 27 references indexed in Scilit:
- Limits of agreement between measures obtained from standard laboratory and the point-of-care device Hemochron Signature Elite® during acute haemorrhageBritish Journal of Anaesthesia, 2014
- Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarinAnnals of Neurology, 2013
- Assessment of point‐of‐care measurement of international normalised ratio using the CoaguChek XS Plus system in the setting of acute ischaemic strokeInternal Medicine Journal, 2013
- Guidelines for the Early Management of Patients With Acute Ischemic StrokeStroke, 2013
- Prehospital thrombolysis in acute strokeNeurology, 2013
- Where are we at with point‐ of‐ care testing in haematology?British Journal of Haematology, 2012
- Risks of Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Receiving Warfarin and Treated With Intravenous Tissue Plasminogen ActivatorJAMA, 2012
- Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trialThe Lancet Neurology, 2012
- Point-of-care testing for coagulation studies in a stroke protocol: a time-saving innovationThe American Journal of Emergency Medicine, 2011
- Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral AnticoagulantsStroke, 2009